SCHEMBL31423273

SCHEMBL31423273

O=C(O)c1cc2ccc(C3CCC3)c(C(=O)NC3CCC3)c2[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 4/20 0.43
▸ NPC1 O15118 5/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ SMYD3 Q9H7B4 2/20 0.39
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ PLA2G7 Q13093 3/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MAOB P27338 1/20 0.36
▸ MTNR1A P48039 1/20 0.36
▸ MTNR1B P49286 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31423210 0.83 CNR2 (0.44) CNR2NPC1RAB9APOLBSMN1; SMN2
SCHEMBL31423247 0.80 CNR2 (0.40) CNR2POLBKDM4EALDH1A1GAA
SCHEMBL31423086 0.79 CNR2 (0.39) CNR2POLBKDM4EALDH1A1GAA
SCHEMBL31423057 0.76 SERPINE1 (0.38) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL31423295 0.76 LMNA (0.42) CNR2NPC1POLBSMN1; SMN2SMYD3
SCHEMBL31422776 0.76 LMNA (0.42) CNR2NPC1POLBSMN1; SMN2SMYD3
SCHEMBL31422872 0.75 CNR2 (0.46) CNR2
SCHEMBL31423163 0.73 NOTUM (0.43) CNR2POLBKDM4EALDH1A1GAA
SCHEMBL31422779 0.73 CNR2 (0.42) CNR2POLBKDM4EALDH1A1GAA
SCHEMBL31422800 0.72 CNR2 (0.36) CNR2POLBKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025085233-A1 NOVEL DERIVATIVES OF QUINOLINONES, AND COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2025-04-24 — — WO disclosed
Send feedback